China Medical System: First Prescriptions for Innovative Drug Lumeblue® Issued in China
On 6 December, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the first prescriptions for the innovative drug Lumeblue ® (Methylthioninium Chloride ...
pharmaphorum1 天
TauRx sees path to FDA filing for tau-targeting Alzheimer's drug
As a result, TauRx opted to use methylthioninium chloride (MTC) as an inactive control, as this provides the same change in colour. MTC has, however, already been studied as an Alzheimer's therapy ...
manilatimes19 天
China Medical System: First Prescriptions for Innovative Drug Lumeblue® Issued in China
SHENZHEN, CHINA, Dec. 08, 2024 (GLOBE NEWSWIRE) -- On 6 December, China Medical System Holdings Limited ("CMS” or the "Group”) is pleased to announce that the first prescriptions for the innovative ...